What's New
DDS

2011/11/7
NOF exhibits DDS products at CPhI India

- Date: 30 November - 2 December 2011
-Location:Bombay Exhibition Centre
- NOF Booth: #N19
URL:http://www.cphi-india.com

2011/10/26
DDS Excipients Catalog ver.13 is Now Available

NOF is pleased to announce our new Catalog for DDS Excipients.
Please do not hesitate to ask us for obtaining the Catalog, together with your contact information.

NOF CORPORATION
DDS Development Division
E-mail : ddsinfo@nof.co.jp

NOF exhibits cutting-edge excipients and tech. for DDS at CPhI Frankfurt

2011/05/15
NOF attends the TIDE 2011 at Boson, MA (May 22-25)

2011/03/17
ICBS2011 has been cancelled due to earthquake in Japan
Due to the major earthquake in northern Japan on Mar. 11, International Conference on Biomaterials Science 2011 in Tsukuba has been cancelled. As one of supporters of this event, we receive the news with sincere regret and express our heartfelt sympathy to earthquake victims. We are praying for speedy recovery of disaster area. URL

2011/02/17 (Update date) NOF co-hosts International Conference on Biomaterials Science 2011 in Tsukuba, Japan (Mar.15-18)

2011/02/04 NOF exhibits cutting-edge excipients & tech at ASIA TIDES in Tokyo (Mar.2-4)

2010/09/28 NOF release New Activated PEG

2010/09/21 NOF's Activated PEG Used in an U.S. FDA Approved PEGylated Drug

2010/09/07 NOF exhibits cutting edge excipients & tech. for DDS in CPhI Worldwide Paris, France (Oct. 5- 7)

2010/07/26 Program for Liposome Conference in Vancouver, Aug 4-8, 2010

2010/07/08 NOF presents at Liposome Conference in Vancouver, Aug 4-8, 2010

2010/06/30 NOF release New Activated PEG

2010/05/21 NOF AMERICA CORPORATION opened a new office in California

On May 7, NOF AMERICA CORPORATION, a wholly owned subsidiary of NOF,
opened a new office in California to further enhance its sales
activities in the North American market
Post Address: 2102 Business Center Drive, Suite 130 Irvine, CA 92612, USA

2010/03/11 NOF partners with ENZON on PEG derivatives PDF

2010/01/07 NOF signs Exclusive Licensing Agreement on Novel Carrier for Gene Delivery PDF